Cargando…
Novel Compound C150 Inhibits Pancreatic Cancer Cell Epithelial-to-Mesenchymal Transition and Tumor Growth in Mice
Pancreatic cancer cell epithelial-to-mesenchymal transition (EMT) is an important contributor to cell invasion and tumor progression. Therefore, targeting EMT may be beneficial for pancreatic cancer treatment. The aim of the present study was to report on the inhibitory effect of the novel compound...
Autores principales: | Wang, Tao, Chen, Ping, Dong, Ruochen, Weir, Scott, Baltezor, Michael, Schoenen, Frank J., Chen, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714879/ https://www.ncbi.nlm.nih.gov/pubmed/34976816 http://dx.doi.org/10.3389/fonc.2021.773350 |
Ejemplares similares
-
Novel compound C150 inhibits pancreatic cancer through induction of ER stress and proteosome assembly
por: Wang, Tao, et al.
Publicado: (2022) -
Epithelial-Mesenchymal Transition and Its Regulation Mechanisms in Pancreatic Cancer
por: Luu, Tuan
Publicado: (2021) -
Targeting Epithelial-Mesenchymal Transition for Identification of Inhibitors for Pancreatic Cancer Cell Invasion and Tumor Spheres Formation
por: Polireddy, Kishore, et al.
Publicado: (2016) -
Role of Epithelial-Mesenchymal Transition in Pancreatic Ductal Adenocarcinoma: Is Tumor Budding the Missing Link?
por: Karamitopoulou, Eva
Publicado: (2013) -
Genomics and Prognosis Analysis of Epithelial-Mesenchymal Transition in Glioma
por: Tao, Chuming, et al.
Publicado: (2020)